WELL Health Technologies Corp. News Releases

WELL Health Strengthens Privacy and AI Governance Leadership with Appointment of Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory

Tue, 20 Oct 2026 06:00:00 -0400

WELL appoints recognized privacy and healthcare law expert Samara Starkman as Chief Privacy Officer and Vice President, Legal & Regulatory, to lead enterprise privacy, AI governance and healthcare regulatory strategy across the organization.Ms. Starkman previously led the privacy department at Cancer Care Ontario (now part of Ontario Health), co-founded INQ Consulting and was a Partner at INQ Law, advising major Ontario hospitals, pharmaceutical and health-tech companies. Ms. Starkman's...

WELL Health Subsidiary WELLSTAR Announces Completion of Amalgamation and Expected Trading Date of "WSTR" on TSXV

Tue, 29 Sep 2026 15:30:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - September 29, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that its subsidiary, WELLSTAR Technologies Corp. ("WELLSTAR") has completed the previously announced amalgamation (the "Transaction") with 1587818 B.C. Ltd. ("818"). The entity...

WELL Health Subsidiary WELLSTAR Announces Conditional Approval for TSXV Listing and Files Filing Statement

Mon, 28 Sep 2026 06:00:00 -0400

WELLSTAR has received conditional approval from the TSX Venture Exchange as a Tier 1 issuer, subject to satisfaction of the TSXV's customary listing conditions, and is expected to commence trading on or around October 1, 2026, under the ticker symbol "WSTR".Vancouver, British Columbia--(Newsfile Corp. - September 28, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) ("WELL"), a digital health company focused on positively impacting health outcomes by leveraging technology to...

WELL Health Launches WELL Research, an End-to-End Clinical Trial Platform Built on Canada's Largest Outpatient Network

Tue, 22 Sep 2026 06:00:00 -0400

WELL Research is the clinical research brand of WELL Health Technologies. WELL Research offers the unique combination of full-service contract research organization (CRO) services in early-phase trials, site management organization (SMO) execution at late-stage trial sites, and bioanalytical services across every phase of clinical trials. Together, these capabilities span the full clinical trial value chain and allow sponsors and providers to enrol the right trial participants quickly and...

WELL Health Announces Planned CFO Transition; Evelyn Sutherland Appointed Chief Financial Officer

Wed, 09 Sep 2026 06:00:00 -0400

WELL has appointed Evelyn Sutherland as Chief Financial Officer, effective September 21, 2026. Ms. Sutherland brings more than 20 years of senior financial leadership experience, including CFO roles at Staples Canada, Enercare Inc., KEYreit, and United Purchasing Group of Canada (Yum! Brands).Ms. Sutherland has served on the Board of WELL's subsidiary, WELLSTAR, over the past year and brings direct knowledge of the Company's strategy, governance and culture to the role.Eva Fong, WELL's...

WELL Health Announces WELLTRUST(TM) Surpasses 100,000 Patient Consents

Tue, 08 Sep 2026 06:30:00 -0400

WELLTRUST™, a WELL-managed database of consented WELL patients, has surpassed 100,000 patient consents since launching in February 2026. Every consent represents a patient who has expressly agreed to be contacted about clinical trials and research studies matched to their health circumstances. HEALWELL's DARWEN™ AI platform is used to connect WELLTRUST™ patients with life sciences companies, including pharma and biotech trial sponsors and Contract Research Organizations (CROs), by matching trial...

WELL Health Redeems $70 Million 5.50% Convertible Debentures

Thu, 20 Aug 2026 06:30:00 -0400

WELL Health redeemed early all of its outstanding 5.50% convertible senior unsecured debentures on August 19, 2026.Vancouver, British Columbia--(Newsfile Corp. - August 20, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, redeemed early all of its outstanding 5.50% convertible senior...

WELL Health Achieves Record Quarterly Revenue Milestone of $400 Million in Q2-2026, Driven by 32% Revenue Growth of Canadian Patient Services, and Raises 2026 Annual Guidance

Thu, 06 Aug 2026 16:00:00 -0400

WELL achieved quarterly revenues of $400.4 million in Q2-2026, an increase of 12% as compared to Q2-2025, driven by strong growth in the Company's Canadian Patient Services Business where quarterly revenue increased by 32% to $151.6 million in Q2-2026 as compared to Q2-2025.WELL achieved Adjusted EBITDA(1) of $48.1 million in Q2-2026, a decrease of 3% as compared to Q2-2025, representing an Adjusted EBITDA Margin(1) of 12%. The decrease reflects the impact of Circle Medical Deferrals(2) which...

WELL Health Strengthens Executive Leadership Team with Appointments of Loreto Grimaldi as Chief Legal Officer and Kaytek Przybylski as Chief Digital & Information Officer

Tue, 04 Aug 2026 06:30:00 -0400

WELL appoints accomplished legal and business executive Loreto Grimaldi as Chief Legal Officer to lead legal, compliance, governance, risk management and M&A activities across the organization.Seasoned technology and digital transformation leader Kaytek Przybylski joins WELL as Chief Digital & Information Officer to lead enterprise technology, digital transformation, data, AI, and cybersecurity and technology shared services strategy.Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026)...

WELL Health to Announce Second Quarter 2026 Financial Results on August 6, 2026

Tue, 04 Aug 2026 06:00:00 -0400

Vancouver, British Columbia--(Newsfile Corp. - August 4, 2026) - WELL Health Technologies Corp. (TSX: WELL) (OTCQX: WHTCF) (the "Company" or "WELL"), a digital healthcare company focused on positively impacting health outcomes by leveraging technology to empower healthcare practitioners and their patients globally, is pleased to announce that the Company will release its Fiscal Second Quarter 2026 financial results for the period ended June 30, 2026, after market close on Thursday, August 6,...